rs7186128
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs7186128(A;A) |
Make rs7186128(A;G) |
Make rs7186128(G;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 16 |
Position | 16864058 |
is a | snp |
is | mentioned by |
dbSNP | rs7186128 |
dbSNP (classic) | rs7186128 |
ClinGen | rs7186128 |
ebi | rs7186128 |
HLI | rs7186128 |
Exac | rs7186128 |
Gnomad | rs7186128 |
Varsome | rs7186128 |
LitVar | rs7186128 |
Map | rs7186128 |
PheGenI | rs7186128 |
Biobank | rs7186128 |
1000 genomes | rs7186128 |
hgdp | rs7186128 |
ensembl | rs7186128 |
geneview | rs7186128 |
scholar | rs7186128 |
rs7186128 | |
pharmgkb | rs7186128 |
gwascentral | rs7186128 |
openSNP | rs7186128 |
23andMe | rs7186128 |
SNPshot | rs7186128 |
SNPdbe | rs7186128 |
MSV3d | rs7186128 |
GWAS Ctlg | rs7186128 |
GMAF | 0.2847 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23478653] |
Trait | Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer |
Title | A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy. |
Risk Allele | G |
P-val | 4E-7 |
Odds Ratio | 2.50 [1.70-3.50] |
[PMID 32295184] MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients.